Research and analysis

ACRE advice: heart failure gene therapy trial

The Advisory Committee on Releases to the Environment's advice on the release of a genetically modified organism for heart research.



This document is the Advisory Committee on Releases to the Environment (ACRE’s) advice to government in considering a request from Celladon Corporation to conduct gene therapy trials. The trial is for research into calcium ion transport in heart failure patients.

The committee decided that the trial would have no risk to human health or the environment, and recommended that the application should be approved.